Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Income from Continuing Operations: 2011-2024

Historic Income from Continuing Operations for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $24.1 million.

  • Veracyte's Income from Continuing Operations rose 26.33% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 426.92%. This contributed to the annual value of $24.1 million for FY2024, which is 132.44% up from last year.
  • According to the latest figures from FY2024, Veracyte's Income from Continuing Operations is $24.1 million, which was up 132.44% from -$74.4 million recorded in FY2023.
  • In the past 5 years, Veracyte's Income from Continuing Operations ranged from a high of $24.1 million in FY2024 and a low of -$75.5 million during FY2021.
  • In the last 3 years, Veracyte's Income from Continuing Operations had a median value of -$36.6 million in 2022 and averaged -$28.9 million.
  • As far as peak fluctuations go, Veracyte's Income from Continuing Operations slumped by 177.06% in 2020, and later spiked by 132.44% in 2024.
  • Veracyte's Income from Continuing Operations (Yearly) stood at -$34.9 million in 2020, then slumped by 116.42% to -$75.5 million in 2021, then soared by 51.61% to -$36.6 million in 2022, then plummeted by 103.51% to -$74.4 million in 2023, then skyrocketed by 132.44% to $24.1 million in 2024.